09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Source Url: https://www.jdsupra.com/legalnews/caremark-round-ii-beware-red-flags-in-18599/
Related
Most employers with more than 10 employees are required to keep a record of serious work-related inj...
Read More >
On January 1, 2020, a new Ohio Administrative Code Rule became effective with respect to payment for...
Read More >
As you are aware from these pages, Connecticut’s General Assembly produced a plethora of bills affe...
Read More >
HR Professionals will soon know the answer to this question. The United States Supreme Court is pr...
Read More >
On January 2, 2020, the Bureau of Indian Affairs (BIA) issued a proposed rule to create a new 25 Cod...
Read More >
Size-of-transaction threshold under Hart-Scott-Rodino Act will decrease to $92 million; the first th...
Read More >